You Position: Home > Paper
Unique hematopoietic stem cell transplantation system in China
( views:178, downloads:4 )
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 16
- DOI:
- 10.3760/cma.j.issn.0366-6999.2011.16.001
- Key Word:
- No keyword available
Abstract： @@ Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective, even the only option to cure patients with certain hematological diseases.HSCT has been applied in China for about 30 years, and great improvement has been made during the past decade.A distinctive HSCT system with Chinese characteristics has been gradually stylized, which manifested in the following aspects.
- [1]陈健琳,冯凯,郭子宽,等.骨髓间充质干细胞抑制异体T淋巴细胞反应的实验研究[J].2005,(12).
- [2]陈峰,吴德沛,孙爱宁,等.非血缘关系与单倍型相合供者造血干细胞移植治疗恶性血液病疗效比较[J].2008,(2).
- [3]Jun CY,Jun HX,Yu ZX.A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts.[J].2005,90(5).
- [4]Franco Aversa,Massimo F.Martelli.Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases[J].2004,26(1/2).
- [5]Jiang Q,Liu KY,Chen SS,etc.Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase.[J].2011,117(11).
- [6]Chen YH,Liu KY,Huang XJ,etc.A pilot study of low-dose recombinant interleukin-2 for acute lymphoblastic malignancy after unmanipulated allogeneic blood and marrow transplantation.[J].2008,42(8).
- [7]Chang YJ,Huang XJ,Zhao XY.Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions.[J].2007,17(3).
- [8]HUANG XIAO-JUN,XU LAN-PING,LIU KAI-YAN.HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: Improved outcomes in patients in accelerated phase and blast crisis phase[J].2008,40(6).
- [9]Liu KY,Huang XJ,Wang J,etc.Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility.[J].2011,46(6).
- [10]Huang XJ,Liu KY,Chen H,etc.Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation.[J].2007,92(3).